Two Day Course: China & Pacific Rim Markets: Compliance Processes for Life Science Products - (Philadelphia, PA, United States - August 23-24, 2018) - ResearchAndMarkets.com

August 10, 2018

DUBLIN--(BUSINESS WIRE)--Aug 10, 2018--The “China & Pacific Rim Markets: Compliance Processes for Life Science Products - Company Establishment, Clinical Trials, Registrations, Renewals and Supply Chain Considerations” conference has been added to ResearchAndMarkets.com’s offering.

This China & Pacific Rim life science compliance-based seminar will discuss the regulatory structure and requirements for compliance with in-country regulations for Pharmaceuticals, Medical Devices, Biologics and Combination Products.

This course is designed to provide a detailed overview of the regulatory requirements, local challenges and important cultural aspects of working with the lifecycle of Life Science Products (pharmaceuticals, medical devices, biologics, combination products) as an importer into China & the Pacific Rim.

China has been improving its regulatory regime governing the food and pharmaceutical industry in recent years. In 2010, by promulgating the amended GMP and amending GLP, GCP, GSP and other regulations, China will further align the country with international standards of practice. For manufacturers and distributors of drugs and medical devices in China, it is important to pay close attention to the pace at which SFDA implements these changes and to make changes to their standard operating procedures when necessary to ensure compliance with the evolving regime.

Other Pacific Rim markets are also growing in importance and interest in access to innovative products. In-country Regulatory Agencies are progressing in their sophistication, process development and regulatory requirements.

This course specifically focuses on the overall regulatory compliance requirements and procedures for Pharmaceuticals, Medical Devices, Biologics and Combination Products in China and the listed Pacific Rim Countries* (Taiwan, Hong Kong, Singapore, Malaysia, Vietnam & Thailand).

The course will cover topics relating to pre-clinical and clinical requirements, as well as, addressing the structure of the regulatory agencies. Content will also include descriptions of the methods by which regulators process filings and registrations and what is expected in the authorization and dossier maintenance of licensed products.

It will provide training on:

The current Regulatory Structure. Understanding the specific procedures for Pharmaceuticals, Medical Devices, Biologics and Combination Products. How to begin your company’s involvement in-country: local licenses, personnel and facilities required. Clinical Trials: Why consider Country X? CTA requirements, the Application Process, CRO Selection and Start-up. The current key regulations effecting product development and your company’s product pipeline. Pricing establishment. Understanding the local concerns and specific challenges in working with Local Regulatory Personnel. Understanding the Local Culture: Realistic expectations, timing on reviews, effective strategies for adding China and countries from the Pacific Rim to your company’s global market presence. Information necessary for effective dossier preparation; or how does one take an already approved dossier and turn it into an acceptable submission package. Strategies for streamlining the registration application process for faster approval. Maintenance of Authorized Products.

For more information about this conference visit https://www.researchandmarkets.com/research/jgjmd7/two_day_course?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180810005148/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biotechnology,Clinical Trials,Supply Chain Management



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/10/2018 06:21 AM/DISC: 08/10/2018 06:20 AM


Update hourly